C. G. Gahlemann

Prolonged Prophylaxis With Valganciclovir Is Cost Effective in Reducing Posttransplant Cytomegalovirus Disease Within the United States

Emily A. Blumberg, Ingeborg A. Hauser, Sanja Stanisic et al. · Transplantation · 2010 · 33 citations

Medicine, Infectious Diseases, Pharmacoeconomics +14

A prospective study comparing safety and efficacy of mycophenolate mofetil versus azathioprine in primary liver transplant recipients

Lutz Fischer, Martina Sterneck, C. G. Gahlemann et al. · Transplantation Proceedings · 2000 · 32 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Mycophenolate mofetil for prevention of liver allograft rejection: initial results of a controlled clinical trial.

Martina Sterneck, Lutz Fischer, C. G. Gahlemann et al. · PubMed · 2000 · 30 citations

Life Sciences, Immunology, Pharmacotherapy +17

Phase I study of gefitinib in combination with oxaliplatin and weekly 5-FU/FA (FUFOX) for second-/third-line treatment in patients (pts) with metastatic colorectal cancer (CRC)

J.T. Hartmann, Hendrik Kroening, C. Bokemeyer et al. · Journal of Clinical Oncology · 2005 · 14 citations

Medicine, Oncology, Pharmacology +13

Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy

Vincent C. Emery, Oriol Manuel, Anders Åsberg et al. · Journal of Clinical Virology · 2012 · 13 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17